169 related articles for article (PubMed ID: 34568427)
1. Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma.
Zang B; Wang W; Wang Y; Li P; Xia T; Liu X; Chen D; Piao HL; Qi H; Ma Y
Front Mol Biosci; 2021; 8():721990. PubMed ID: 34568427
[TBL] [Abstract][Full Text] [Related]
2. PES1 reduces CD8
Ma N; Hua R; Yang Y; Liu ZC; Pan J; Yu BY; Sun YF; Xie D; Wang Y; Li ZG
J Biomed Sci; 2023 Mar; 30(1):20. PubMed ID: 36959575
[TBL] [Abstract][Full Text] [Related]
3. Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma.
Chen Z; Dai Y; Huang X; Chen K; Gao Y; Li N; Wang D; Chen A; Yang Q; Hong Y; Zeng S; Mao W
Front Oncol; 2020; 10():1545. PubMed ID: 32984013
[No Abstract] [Full Text] [Related]
4. Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma.
Wang PP; Song X; Zhao XK; Wei MX; Gao SG; Zhou FY; Han XN; Xu RH; Wang R; Fan ZM; Ren JL; Li XM; Wang XZ; Yang MM; Hu JF; Zhong K; Lei LL; Li LY; Chen Y; Chen YJ; Ji JJ; Yang YZ; Li J; Wang LD
Front Oncol; 2022; 12():790933. PubMed ID: 35155234
[TBL] [Abstract][Full Text] [Related]
5. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
[TBL] [Abstract][Full Text] [Related]
7. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
8. ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease.
Bremer HD; Landegren N; Sjöberg R; Hallgren Å; Renneker S; Lattwein E; Leonard D; Eloranta ML; Rönnblom L; Nordmark G; Nilsson P; Andersson G; Lilliehöök I; Lindblad-Toh K; Kämpe O; Hansson-Hamlin H
Sci Rep; 2018 Mar; 8(1):4852. PubMed ID: 29556082
[TBL] [Abstract][Full Text] [Related]
9. Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma.
Wang Z; Zhang Y; Yang X; Zhang T; Li Z; Zhong Y; Fang Y; Chong W; Chen H; Lu M
Sci Rep; 2024 Mar; 14(1):6200. PubMed ID: 38486026
[TBL] [Abstract][Full Text] [Related]
10. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
[TBL] [Abstract][Full Text] [Related]
11. Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry.
Zhang S; Lu X; Hu C; Li Y; Yang H; Yan H; Fan J; Xu G; Abnet CC; Qiao Y
ACS Omega; 2020 Oct; 5(41):26402-26412. PubMed ID: 33110968
[TBL] [Abstract][Full Text] [Related]
12. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
13. LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma.
Mir SA; Rajagopalan P; Jain AP; Khan AA; Datta KK; Mohan SV; Lateef SS; Sahasrabuddhe N; Somani BL; Keshava Prasad TS; Chatterjee A; Veerendra Kumar KV; VijayaKumar M; Kumar RV; Gundimeda S; Pandey A; Gowda H
J Proteomics; 2015 Sep; 127(Pt A):96-102. PubMed ID: 25982385
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analyses of long non-coding RNA expression profiles and functional network analysis in esophageal squamous cell carcinoma.
Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
Sci Rep; 2019 Jun; 9(1):9162. PubMed ID: 31235759
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of the mouse interleukin enhancer binding factor 3 (Ilf3) homolog in a screen for RNA binding proteins.
Buaas FW; Lee K; Edelhoff S; Disteche C; Braun RE
Mamm Genome; 1999 May; 10(5):451-6. PubMed ID: 10337617
[TBL] [Abstract][Full Text] [Related]
16. Multi-Omics Analysis Reveals the Role of Changes in Platelet Activation Pathways in the Survival Outcome of Patients with Esophageal Squamous Cell Carcinoma.
Wang H; Li Z; Yao X; Cheng L; Liu Q; Hu Q; Zhou Q; Yang Q; He H; Cai S; Fang L; Li K; Wang Z; Wen H; Zhou C; Fu M; Cao C
Altern Ther Health Med; 2024 Feb; ():. PubMed ID: 38401086
[TBL] [Abstract][Full Text] [Related]
17. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
18. High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma.
Xu Z; Huang H; Li X; Ji C; Liu Y; Liu X; Zhu J; Wang Z; Zhang H; Shi J
Oncol Lett; 2020 Mar; 19(3):2141-2152. PubMed ID: 32194712
[TBL] [Abstract][Full Text] [Related]
19. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers.
Zhu ZJ; Qi Z; Zhang J; Xue WH; Li LF; Shen ZB; Li ZY; Yuan YL; Wang WB; Zhao J
J Cancer; 2020; 11(13):3944-3954. PubMed ID: 32328198
[No Abstract] [Full Text] [Related]
20. Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts.
Ma F; Laster K; Nie W; Liu F; Kim DJ; Lee MH; Bai R; Yang R; Liu K; Dong Z
J Cancer; 2021; 12(13):3930-3944. PubMed ID: 34093800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
